Vivus Is Preparing Revised TV Ads For Muse Following FDA NOV Letter
Executive Summary
Vivus is in discussions with FDA regarding revised TV broadcast ads for its erectile dysfunction therapy, Muse (alprostadil), following receipt of a notice of violation letter from the agency objecting to certain aspects of the company's TV and print ad campaigns.